TSBX
Turnstone Biologics
TSBX
TSBX
Delisted
TSBX was delisted on the 8th of August, 2025.
28 hedge funds and large institutions have $5.51M invested in Turnstone Biologics in 2024 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 6 increasing their positions, 6 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
28
Holders Change
+4
Holders Change %
+16.67%
% of All Funds
0.37%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
7
Increased
6
Reduced
6
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
$33.3K |
| 2 |
Citigroup
New York
|
$30.4K |
| 3 |
Renaissance Technologies
New York
|
$11.9K |
| 4 |
Goldman Sachs
New York
|
$10.2K |
| 5 |
BNP Paribas Financial Markets
Paris,
France
|
$7.57K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
26
Morgan Stanley
New York
| $2.34K | -$646 | -1,300 | -22% |
|
27
JPMorgan Chase & Co
New York
| $98 | +$20 | +41 | +26% |
|
28
UBS Group
Zurich,
Switzerland
| $35 | -$5.21K | -10,572 | -99% |
|
|
ECM
29
ExodusPoint Capital Management
New York
| – | -$253K | -454,026 | Closed |
|
30
Balyasny Asset Management
Chicago,
Illinois
| – | -$27.8K | -49,880 | Closed |
|
|
CFM
31
Catalyst Funds Management
Sydney NSW,
Australia
| – | -$446 | -800 | Closed |
|